NASDAQ

OnKure Therapeutics, Inc. - Class A (OKUR)

♥ 579 Thanks from members

Live price chart, market sentiment, and community perspectives for OnKure Therapeutics, Inc. - Class A (NASDAQ: OKUR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: OnKure Therapeutics Research TeamLeadership: Heidi Henson (President and CEO)Holder: Bain Capital Life SciencesHolder: Boxer CapitalHolder: RA Capital ManagementOKI-219PI3K/AKT Pathway Inhibitors#OKUR#OnKure Therapeutics#Precision Oncology#Cancer Therapeutics#NASDAQ OKUR